We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Association of Platform Shifting with Bone Remodeling and Cytokine Levels in Peri-implant Sulcus Fluid in Single Tooth Implants: A Split-mouth Study.
- Authors
Singla, Shefali; Kumar, Lalit; Gupta, Mili; Kaur, Manjot
- Abstract
Purpose: The purpose of this prospective split-mouth study was to compare crestal bone loss (CBL) and interleukin-1γ (IL-1γ) and C-terminal telopeptide (CTX) levels in peri-implant sulcus fluid (PISF) between implants restored with platform matched (PM) and platform switched (PS) abutments. Materials and methods: A total of 50 single tooth implants of 4.6 mm diameter were placed crestally in 25 patients (two implants in each patient) in the molar region. After 3 months, each of the two implant sites in each patient was randomly restored with a PM and a PS abutment (3.8 mm), and prostheses were given. The bone loss was calculated using a digital radiograph after abutment placement (baseline), 6 months, 1 year, and 2 years of loading. During each interval, PISF was collected around the implant and IL-1γ and CTX were estimated using an enzymelinked immune sorbent assay. The mean difference in bone loss and IL-1γ levels within and between the two groups were compared using one-way analysis of variance (ANOVA) and independent t-tests. About 80% of PISF samples at baseline and 90% of samples of subsequent visits developed very negligible or no color and thus were considered negative for CTX. Results: The bone loss found at baseline was 0.82 ± 0.54 mm in the PM group and 0.69 ± 0.47 mm in the PS group (p = 0.376). At 6 months, the total bone loss was 1.05 ± 0.62 mm in the PM group and 0.97 ± 0.58 mm in the PS group, and increased to 1.11 ± 0.60 and 1.03 ± 0.64 mm, respectively in 2 years of follow-up. IL-1γ levels were 4.52 ± 5.24 and 5.30 ± 6.38 ng/mL in the PM and PS groups, respectively (p = 0.175) at baseline. The levels decreased to 0.73 ± 0.83 ng/mL and 0.59 ± 0.54 ng/mL in the two groups, respectively, at 2-year follow-up. An insignificant difference was found in bone loss and IL-1γ levels of both groups during the follow-up. Conclusion: Within the limitation of the study, the extent of bone loss and PISF IL-1γ levels were insignificantly different when PM and PS abutments were used with the same implant system. IL-1γ levels reflected the extent of inflammation associated with the implant site, which decreased with time.
- Subjects
BONE remodeling; DENTAL implants; DENTAL abutments; CYTOKINES; MEDICAL digital radiography; ANALYSIS of variance
- Publication
International Journal of Prosthodontics & Restorative Dentistry, 2024, Vol 14, Issue 1, p10
- ISSN
2231-6361
- Publication type
Article